Peptide Services
Peptide drugs, composed of short chains of amino acids, represent a promising class of therapeutics with unique advantages over traditional small-molecule drugs. The global peptide therapeutics market is experiencing significant growth, driven by the rising prevalence of chronic diseases and advancements in peptide drug development.
Advantages Over Small Molecules
• High target specificity
• High target affinity
• Fewer side effects
• Less accumulation in tissues
General Advantages of Peptides
• Highly potent and selective
• Less toxic
• Low cost
Advantages Over Other Biologics
• High membrane permeability
• Less immunogenic
• Synthetically facile
DEL and Display for de novo Peptide Discovery
WuXi Biology offers end-to-end peptide discovery solutions – from library synthesis and screening to validation. Our DEL and display platforms enable multiple approaches: Peptide DEL, mRNA display, and phage display, each with unique advantages. [Click to explore more]
Integrated Bioassay Platform
Peptide as a new modality, has been widely used in different aspects of drug discovery: not only can peptide be used as therapeutic molecule, it can also serve as a tool for specific target-medicated delivery. In both applications, the effectiveness of peptide has been studied on large selections of targets critical in diseases including oncology, immunology, metabolic diseases et al.
① Recommended assays for testing specific features
② Search our database for ready-to-go assays for your target
③ Find our experience in different disease areas
Peptide Optimization
Peptide Optimization Capabilities
1. In Silico Methods
2. SBDD
3. D2B
4. Focused Peptide DEL
Cost- and time-efficient peptide synthesis and validation by “D2B” approach
• Resynthesis and validation of screened hit peptides
• Fast SAR exploration and optimization of hit peptide
• Rapidly expand the patent space
